We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Process Validation for Harvesting Biotech-Derived Proteins Focus of EMA Guideline
Process Validation for Harvesting Biotech-Derived Proteins Focus of EMA Guideline
Drugmakers that are obtaining biotechnology-derived proteins in the EU should include effective evaluation and verification studies in their process validation documentation, the European Medicines Agency says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor